Privia Health Group (PRVA)
PRVAPrivia Health Group
-$0.35 (-0.8%)

Privia Health Group Stock Analysis & Ratings

Privia Health Group Stock Analysis Overview

Smart Score
Learn more about TipRanks Smart Score
The Privia Health Group stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart


PRVA Stock Stats

Previous Close$43.42
Bid39.44 x 100
Ask4294.67 x 100
Today’s Range$0 - $0
52-Week Range$27.15 - $50.77
Average Volume535.87K
Market Cap$4.59B
P/E Ratio144.3
Earnings DateAug 09, 2021

Company Description

Privia Health Group

Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Healthcare Providers & Services
M. Shawn Morris
950 N. Glebe Road, Arlington, VA, 22203, US


P/E Ratio Range

Currently, no data available
Please return soon. This page is being updated.
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


What was Privia Health Group’s price range in the past 12 months?
Privia Health Group lowest stock price was $27.15 and its highest was $50.77 in the past 12 months.
    What is Privia Health Group’s market cap?
    Privia Health Group’s market cap is $4.59B.
      What is Privia Health Group’s price target?
      The average price target for Privia Health Group is $50.00. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $57.00 ,the lowest forecast is $40.00. The average price target represents 15.15% Increase from the current price of $43.42.
        What do analysts say about Privia Health Group?
        Privia Health Group’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
          When is Privia Health Group’s upcoming earnings report date?
          Privia Health Group’s upcoming earnings report date is Aug 09, 2021 which is in 10 days.
            How were Privia Health Group’s earnings last quarter?
            Privia Health Group released its earnings results on May 27, 2021. The company reported $0.056 earnings per share for the quarter, beating the consensus estimate of $0.043 by $0.013.
              Is Privia Health Group overvalued?
              According to Wall Street analysts Privia Health Group’s price is currently Undervalued.
                Does Privia Health Group pay dividends?
                Privia Health Group does not currently pay dividends.
                What is Privia Health Group’s EPS estimate?
                Privia Health Group’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Privia Health Group have?
                Privia Health Group has 105,730,000 shares outstanding.
                  What happened to Privia Health Group’s price movement after its last earnings report?
                  Privia Health Group reported an EPS of $0.056 in its last earnings report, beating expectations of $0.043. Following the earnings report the stock price went down -1.118%.
                    Which hedge fund is a major shareholder of Privia Health Group?
                    Currently, no hedge funds are holding shares in PRVA

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis